GO
| HSI1 | 25,021.54 | -42.17 | 156.94B |
| HSCEI1 | 8,462.07 | -37.46 | 58.00B |
| Back Zoom + Zoom - Block Traded | |
|
INNOVENT BIO-Eli Lilly Strategic Collaboration Deal Takes Effect; Rumored Acquisition Intent Not True
2026-03-25 08:27:49 Regarding the signing of a strategic collaboration agreement with Eli Lilly (LLY.US) to advance novel medicines in oncology and immunology, INNOVENT BIO (01801.HK) announced that it had obtained early clearance from the Federal Trade Commission, and hence, all the conditions precedent to the effectiveness of its strategic collaboration agreement with Eli Lilly had been satisfied. This agreement became effective on March 24 (Hong Kong time). INNOVENT BIO also noted that certain media reports had incorrectly interpretated the effectiveness of the strategic collaboration agreement as an acquisition of the company. INNOVENT BIO clarified that it is not engaged in, nor has any intention of pursuing such transaction. ~ AAStocks Financial News Web Site: www.aastocks.com | |